The selection of chloroquine and remdesivir as standard drugs is based on scientific evidence stating that only chloroquine and remdesivir, as marketed drugs, have been proven to be active as an ACE2 and Mpro inhibitor, respectively, in COVID-19 treatment [12,16]. Here, ACE2 is linked to COVID-19.